Middle East and Africa Protein Expression Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Protein Expression is an ability to control, produce and change the protein in an organism. In research, the term protein expression refers to the laboratory technique or material of study to formulate proteins. Recombining of protein expression is of three types, in-vivo protein expression, in-vitro protein expression and chemical protein synthesis. A large number of opportunities is in proteomics and biotechnology which mostly depend on protein expression to reduce the side effects and for various therapies.

The Middle East & Africa Protein Expression MarketSegments Size & Growth:

The Middle East & Africa Protein Expression Market is accounted for $4.9 billion in 2017 and expected to grow at a CAGR of 9.18% to reach $8.2 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth an increase in chronic diseases like diabetes and cancer, development in biologics such as therapeutic proteins, vaccines, high investments for drug designing, advancement in biotechnology, biopharmaceutical and so on. However, government regulations for manufacturing biologics hinder the growth of the protein expression market.

The Middle East & Africa Protein Expression Market Segments Share:

The Middle East & Africa Protein Expression Market is categorised into by expression type which consists of prokaryotic, yeast, cell-free, mammalian and so on. The prokaryotic expression has the most significant share as they are cheaper compared to others. By product type, protein expression market is segmented as reagent, instruments, and services. Among all reagents are expected to have high growth rate during the forecast period 2018-2024, due to increase in research activities and vaccines. The application is segregated into therapeutic, industrial, research and others. Therapeutic is expected to have the most significant share in the market due to chronic diseases.

Biotechnology and pharmaceutical are leading in protein expression among end users owing to the rise in technological advancements, research, and manufacturing of therapeutic proteins. By Geography, South Africa is dominating the protein expression market, and the growth in Middle East & Africa is mainly attributed because of the increasing adoption of well-established healthcare facilities and R&D activities. Furthermore, Middle East is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.

The Middle East & Africa Protein Expression Market Segments Trends:

• The Middle East & Africa Protein expression equipment such as ultrasound systems and dialysis bags perform tasks with higher accuracy, speed and help to reduce cost.
• New technologies such as NEB expression technology provide a strategy that best suitable for your protein expression and purification need.
• In January 2017, Bio-Rad Technologies acquired RainDance Technologies to expand its operations in the Middle East & Africa region.

The Middle East & Africa Protein Expression Research Report:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOTanalysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
• Regional and the Middle East & Africa diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Agilent Technologies
• Accelagen Inc.
• EMD Millipore
• Synthetic Genomics Inc.
• Sigma Aldrich Corporation